Adherence to oral antihypertensive medications, are all medications equal?
Journal
Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
15
08
2018
revised:
10
11
2018
accepted:
27
11
2018
pubmed:
9
2
2019
medline:
17
6
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
Good medication adherence is a key factor in chronic disease management. Poor adherence is associated with adverse outcomes and high costs. We aimed to explore adherence rates among oral antihypertensive medications. The study included members of the Central District of Clalit Health Services in Israel aged between 40 and 75 years, who were diagnosed with hypertension before 2012 and who filled at least one prescription per year during 2012-2014, for the following medications: hydrochlorothiazide, nifedipine, amlodipine, lercanidipine hydrochloride, atenolol, bisoprolol, angiotensin-converting enzyme inhibitors (ACEI), angiotensin II receptor antagonists (ARBs), and statins. Purchase of at least nine monthly prescriptions during 2013 was considered as "good medication adherence." We compared systolic blood pressure and LDL levels, according to medication adherence, for each medication and cross-adherence rates between medications. The study included 31 530 subjects. The rates of good medication adherence varied widely among the medications investigated, ranging from 53% for statins and hydrochlorothiazide to 71% for amlodipine. Mean systolic BP and LDL levels were statistically significantly lower among persons with good, compared to lower adherence, for each of the medications investigated. Both advanced age and more chronic medications were associated with higher adherence rates for all medications tested. Poor adherence to any single medication was found to be associated with lower adherence to other medications. Different antihypertensive medications have different adherence rates. Since adherence to one medication is related to adherence to other medications, investing in medication adherence may be highly beneficial.
Identifiants
pubmed: 30734469
doi: 10.1111/jch.13475
pmc: PMC8030303
doi:
Substances chimiques
Antihypertensive Agents
0
Lipoproteins, LDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
243-248Informations de copyright
©2019 Wiley Periodicals, Inc.
Références
Eur J Clin Pharmacol. 2018 Mar;74(3):357-364
pubmed: 29199370
Circ J. 2012;76(6):1415-22
pubmed: 22447014
PLoS One. 2018 Mar 9;13(3):e0194081
pubmed: 29522561
Hypertension. 2016 Sep;68(3):565-75
pubmed: 27432867
Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):983-91
pubmed: 19623570
Patient Educ Couns. 2018 Sep;101(9):1654-1660
pubmed: 29731180
Curr Med Res Opin. 2018 Sep;34(9):1613-1625
pubmed: 29770718
Eur J Health Econ. 2016 Jun;17(5):603-10
pubmed: 26077551
Medicine (Baltimore). 2017 Jan;96(4):e5641
pubmed: 28121920
J Hypertens. 2017 Dec;35(12):2346-2357
pubmed: 28777133
Clin Ther. 2014 Apr 1;36(4):494-506
pubmed: 24508418
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
Clin Med Res. 2013 Jun;11(2):54-65
pubmed: 23580788
Prim Care Diabetes. 2017 Aug;11(4):360-364
pubmed: 28420583
Med Care. 2018 Mar;56(3):266-273
pubmed: 29309392
Curr Med Res Opin. 2013 Oct;29(10):1275-86
pubmed: 23815104
J Clin Hypertens (Greenwich). 2019 Feb;21(2):243-248
pubmed: 30734469
N Engl J Med. 2005 Aug 4;353(5):487-97
pubmed: 16079372
BMC Health Serv Res. 2016 Jul 08;16:236
pubmed: 27391223
PLoS One. 2012;7(3):e32412
pubmed: 22403654